[go: up one dir, main page]

SE0100193D0 - Method for the preparation of citalopram - Google Patents

Method for the preparation of citalopram

Info

Publication number
SE0100193D0
SE0100193D0 SE0100193A SE0100193A SE0100193D0 SE 0100193 D0 SE0100193 D0 SE 0100193D0 SE 0100193 A SE0100193 A SE 0100193A SE 0100193 A SE0100193 A SE 0100193A SE 0100193 D0 SE0100193 D0 SE 0100193D0
Authority
SE
Sweden
Prior art keywords
citalopram
preparation
palladium catalyst
zinc
cyanide
Prior art date
Application number
SE0100193A
Other languages
English (en)
Other versions
SE0100193L (sv
SE516690C2 (sv
Inventor
Hans Petersen
Michael Harold Rock
Henrik Svane
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SE0100193D0 publication Critical patent/SE0100193D0/sv
Publication of SE0100193L publication Critical patent/SE0100193L/sv
Publication of SE516690C2 publication Critical patent/SE516690C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44Palladium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
SE0100193A 1999-06-25 2001-01-24 Förfarande för framställning av citalopram SE516690C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900920 1999-06-25
PCT/DK1999/000640 WO2000013648A2 (en) 1999-06-25 1999-11-22 Method for the preparation of citalopram

Publications (3)

Publication Number Publication Date
SE0100193D0 true SE0100193D0 (sv) 2001-01-24
SE0100193L SE0100193L (sv) 2001-04-25
SE516690C2 SE516690C2 (sv) 2002-02-12

Family

ID=8099035

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100193A SE516690C2 (sv) 1999-06-25 2001-01-24 Förfarande för framställning av citalopram

Country Status (36)

Country Link
US (2) US20020077353A1 (sv)
EP (1) EP1159274B1 (sv)
JP (1) JP3447267B2 (sv)
KR (1) KR100491368B1 (sv)
CN (2) CN1140521C (sv)
AR (1) AR020863A1 (sv)
AT (3) AT409961B (sv)
AU (2) AU1374500A (sv)
BG (1) BG65574B1 (sv)
BR (1) BR9917368B1 (sv)
CA (2) CA2290127C (sv)
CH (1) CH691305A5 (sv)
CZ (1) CZ292198B6 (sv)
DE (2) DE69906389T2 (sv)
DK (2) DK1159274T3 (sv)
EA (1) EA002560B1 (sv)
ES (2) ES2194545T3 (sv)
FI (1) FI108641B (sv)
GB (2) GB2357761B (sv)
HK (1) HK1049002B (sv)
HU (1) HUP0103235A3 (sv)
IL (2) IL145959A0 (sv)
IS (1) IS2343B (sv)
IT (1) ITMI991581A1 (sv)
MX (1) MXPA01010989A (sv)
NO (1) NO328542B1 (sv)
NZ (1) NZ514979A (sv)
PL (1) PL205579B1 (sv)
PT (1) PT1159274E (sv)
SE (1) SE516690C2 (sv)
SI (1) SI1159274T1 (sv)
SK (1) SK285813B6 (sv)
TR (1) TR200103702T2 (sv)
UA (1) UA63034C2 (sv)
WO (1) WO2000013648A2 (sv)
ZA (1) ZA200108854B (sv)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100454008B1 (ko) 1998-12-23 2004-10-20 하. 룬트벡 아크티에 셀스카브 5-시아노프탈리드의 제조방법
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
SI1173431T2 (sl) 1999-04-14 2009-12-31 Lundbeck & Co As H Postopek za pripravo citaloprama
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
TR200101874T1 (tr) 1999-10-25 2002-02-21 H. Lundbeck A/S Sitalopram hazırlanması için yöntem
HUP0200169A3 (en) 1999-10-25 2002-11-28 Lundbeck & Co As H Method for the preparation of citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
SI1246812T1 (en) 1999-12-28 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
SI1246813T1 (en) 1999-12-30 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
CZ20022601A3 (cs) 2000-01-14 2002-10-16 H. Lundbeck A/S Způsob výroby 5-kyanoftalidu
FR2805812A1 (fr) 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
TR200202195T2 (tr) 2000-03-13 2002-12-23 H. Lundbeck A/S 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi
NZ521201A (en) 2000-03-13 2004-02-27 H Method for the preparation of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
PL360107A1 (en) 2000-03-14 2004-09-06 H.Lundbeck A/S Method for the preparation of citalopram
WO2001068632A1 (en) * 2000-03-16 2001-09-20 H. Lundbeck A/S Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CZ2002832A3 (cs) * 2000-07-06 2002-05-15 H. Lundbeck A/S Způsob výroby citalopramu
IL144816A (en) * 2000-08-18 2005-09-25 Lundbeck & Co As H Method for the preparation of citalopram
ES2228824T3 (es) * 2000-12-22 2005-04-16 H. Lundbeck A/S Metodo de preparacion de citalopram puro.
ATE222899T1 (de) * 2000-12-28 2002-09-15 Lundbeck & Co As H Verfahren zur herstellung von reinem citalopram
EP1355897A1 (en) 2001-01-30 2003-10-29 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
WO2002072565A1 (en) * 2001-03-09 2002-09-19 Ranbaxy Laboratories Limited Process for the preparation of citalopram
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
WO2003057132A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
WO2004085416A1 (en) * 2003-03-24 2004-10-07 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
KR101166280B1 (ko) 2004-08-23 2013-11-27 썬 파마 글로벌 에프제트이 시탈로프램 및 에난티오머의 제조 방법
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram
CN114763343B (zh) * 2021-01-14 2026-02-10 浙江华海药业股份有限公司 一种西酞普兰或s-西酞普兰的纯化方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (sv) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
DK1015416T3 (da) * 1997-07-08 2001-11-05 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
SK283907B6 (sk) * 1997-11-11 2004-04-06 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
ES2189502T3 (es) * 1998-10-20 2003-07-01 Lundbeck & Co As H Metodo para la prevencion de citalopram.
KR100454008B1 (ko) * 1998-12-23 2004-10-20 하. 룬트벡 아크티에 셀스카브 5-시아노프탈리드의 제조방법
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
SI1173431T2 (sl) * 1999-04-14 2009-12-31 Lundbeck & Co As H Postopek za pripravo citaloprama
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
TR200101874T1 (tr) * 1999-10-25 2002-02-21 H. Lundbeck A/S Sitalopram hazırlanması için yöntem
AR026063A1 (es) * 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
FR2805812A1 (fr) * 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
IL144816A (en) * 2000-08-18 2005-09-25 Lundbeck & Co As H Method for the preparation of citalopram
ES2228824T3 (es) * 2000-12-22 2005-04-16 H. Lundbeck A/S Metodo de preparacion de citalopram puro.
ATE222899T1 (de) * 2000-12-28 2002-09-15 Lundbeck & Co As H Verfahren zur herstellung von reinem citalopram

Also Published As

Publication number Publication date
WO2000013648A2 (en) 2000-03-16
NZ514979A (en) 2004-01-30
PT1159274E (pt) 2003-08-29
GB0101504D0 (en) 2001-03-07
SE0100193L (sv) 2001-04-25
EA002560B1 (ru) 2002-06-27
AT409961B (de) 2002-12-27
BR9917368B1 (pt) 2010-02-09
CH691305A5 (de) 2001-06-29
AU1374500A (en) 2000-03-27
TR200103702T2 (tr) 2002-06-21
DK1159274T3 (da) 2003-07-21
CA2475401A1 (en) 2000-12-25
BR9917368A (pt) 2002-03-05
ZA200108854B (en) 2002-08-28
CN1140521C (zh) 2004-03-03
JP3447267B2 (ja) 2003-09-16
IS2343B (is) 2008-02-15
GB2357761B (en) 2001-09-05
ES2194545T3 (es) 2003-11-16
IS5861A (is) 2001-02-23
GB2354239B (en) 2001-06-06
CN1502616A (zh) 2004-06-09
AU2001100440B4 (en) 2002-01-24
DE69906389T2 (de) 2003-10-30
DK200100060A (da) 2001-04-10
HUP0103235A3 (en) 2003-01-28
EP1159274B1 (en) 2003-03-26
AT4365U1 (de) 2001-06-25
US20020077353A1 (en) 2002-06-20
WO2000013648B1 (en) 2001-03-15
DE19983487C1 (de) 2002-07-25
CZ2001320A3 (en) 2001-05-16
ITMI991581A0 (it) 1999-07-15
DE69906389D1 (de) 2003-04-30
WO2000013648A8 (en) 2000-05-11
ITMI991581A1 (it) 2001-01-15
EA200101072A1 (ru) 2002-02-28
NO20010319L (no) 2001-02-23
SI1159274T1 (en) 2003-10-31
WO2000013648A3 (en) 2000-07-13
FI108641B (sv) 2002-02-28
CA2290127A1 (en) 2000-12-25
JP2002526386A (ja) 2002-08-20
IL145959A (en) 2007-07-24
NO328542B1 (no) 2010-03-15
IL145959A0 (en) 2002-07-25
NO20010319D0 (no) 2001-01-19
BG65574B1 (bg) 2009-01-30
HK1049002B (zh) 2004-12-31
SE516690C2 (sv) 2002-02-12
HK1049002A1 (en) 2003-04-25
ATE235478T1 (de) 2003-04-15
GB2357761A (en) 2001-07-04
EP1159274A2 (en) 2001-12-05
PL346237A1 (en) 2002-01-28
MXPA01010989A (es) 2002-06-04
HUP0103235A2 (hu) 2002-01-28
AR020863A1 (es) 2002-05-29
ATA904199A (de) 2002-05-15
AU2001100440A4 (en) 2001-11-01
KR20020012204A (ko) 2002-02-15
KR100491368B1 (ko) 2005-05-24
CA2290127C (en) 2005-01-25
SK285813B6 (sk) 2007-08-02
PL205579B1 (pl) 2010-05-31
SK18402001A3 (sk) 2002-06-04
CZ292198B6 (cs) 2003-08-13
ES2189699A1 (es) 2003-07-01
BG106191A (en) 2002-08-30
US20090088469A1 (en) 2009-04-02
CN1367786A (zh) 2002-09-04
GB0105182D0 (en) 2001-04-18
FI20010155L (sv) 2001-02-09
GB2354239A (en) 2001-03-21
UA63034C2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
SE0100193D0 (sv) Method for the preparation of citalopram
BR0213421A (pt) método para formar uma camada de metal condutor em uma superfìcie não condutora
ID27584A (id) Katalis kompleks sianida logam ganda yang diperlakukan dengan asam
ATE288497T1 (de) Verstärkte katalysierte reporterabscheidung
DK1438321T3 (da) Modificeret L-nukleinsyre
FR16C0033I2 (fr) Methode de formation de composes d'hydroxypyrone de fer
FI20012450L (sv) Förfarande för fällning av järn i form av hematit ur zinksulfatlösning
FR2826961B1 (fr) Procede de preparation d'anhydride (meth) acrylique
NZ504084A (en) Processes for producing 7-isoindolinequinolonecarboxylic derivatives and its intermediates, as well as salts of 7-isoindolinequinolonecarboxylic acid derivatives, its hydrates and composition comprising the same as active ingredient
TR200003003T2 (tr) Titanyum bileşimi, içeren katalizatör oluşumu
ES8802012A1 (es) Un procedimiento para preparar derivados arilicos de diemanidas.
FR2838295B1 (fr) Utilisation de sels metalliques du gluconate pour la fabrication de substrats a activite antimicrobienne
DE59701074D1 (de) Elektromagnetisches relais und verfahren zu dessen herstellung
EA199900419A1 (ru) Способ получения солей гидроксиламмония
PL331419A1 (en) Method of grafting a substituted difluoromethyl group
IL157495A0 (en) Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs
ES2107164T3 (es) Procedimiento para la fabricacion de nicotinaldehido acuoso.
ES456367A1 (es) Procedimiento para la preparacion de un ester.
AR020097A1 (es) Sal de n-terc-butilhidroxilamina con acidos carboxilicos c1-4 y procesos para su preparacion, aislacion y purificacion.
ATE130292T1 (de) Hydrierung.
DE59701119D1 (de) Verfahren zur herstellung eines elektromagnetischen relais
DK0924195T3 (da) Fremgangsmåde til fremstilling af aminocyanacetamid
SU1183892A1 (ru) Способ определени никел
MXPA04000513A (es) Proceso para la preparacion de 4-metilamino-4-fenilpiperidina.
ES2186165T3 (es) Procedimiento para preparar 3-isocromanona.

Legal Events

Date Code Title Description
NUG Patent has lapsed